2008
DOI: 10.1016/j.autneu.2008.09.006
|View full text |Cite
|
Sign up to set email alerts
|

The development of nicotinic receptors in the human medulla oblongata: Inter-relationship with the serotonergic system

Abstract: Maternal cigarette smoking during pregnancy adversely affects fetal development and increases the risk for the sudden infant death syndrome (SIDS). In SIDS we have reported abnormalities in the medullary serotonergic (5-HT) system, which is vital for homeostatic control. In this study we analyzed the inter-relationship between nicotinic receptors (nAChRs), to which nicotine in cigarette smoke bind, and the medullary 5-HT system in the human fetus and infant as a step towards determining the mechanisms whereby … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
29
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 31 publications
(31 citation statements)
references
References 98 publications
(141 reference statements)
2
29
0
Order By: Relevance
“…67 Nicotinic acetylcholine receptors are strongly associated with serotonergic (5-HT receptors) in the brainstem during fetal development, and abnormalities of serotonergic neurotransmission in the brainstem have been consistent with neuropathologic findings in cases of sudden unexpected and unexplained death in infancy. 74,75 In first-trimester human fetuses, abnormal nicotinic receptor subunit levels have also been detected in the brainstem regions associated with sudden infant death syndrome. 76 Dysfunction of these brainstem regions, which can be associated with sudden infant death syndrome, is strongly associated with maternal cigarette use during pregnancy, and the alterations that are seen with gene expression in these cholinergic receptor subunits may be a contributing factor to the brainstem abnormalities seen in these infants.…”
Section: Health Consequences Of Exposure To Nicotinementioning
confidence: 99%
“…67 Nicotinic acetylcholine receptors are strongly associated with serotonergic (5-HT receptors) in the brainstem during fetal development, and abnormalities of serotonergic neurotransmission in the brainstem have been consistent with neuropathologic findings in cases of sudden unexpected and unexplained death in infancy. 74,75 In first-trimester human fetuses, abnormal nicotinic receptor subunit levels have also been detected in the brainstem regions associated with sudden infant death syndrome. 76 Dysfunction of these brainstem regions, which can be associated with sudden infant death syndrome, is strongly associated with maternal cigarette use during pregnancy, and the alterations that are seen with gene expression in these cholinergic receptor subunits may be a contributing factor to the brainstem abnormalities seen in these infants.…”
Section: Health Consequences Of Exposure To Nicotinementioning
confidence: 99%
“…Impairments in central cholinergic system are implicated in pathophysiology of some prevalent neurological disorders involving respiratory control such as SIDS and sleep apnea [13,[22][23][24][25][26] . Studies of central cholinergic regulation of respiration date to the early 1930s.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, ␣4-containing nAChRs reside in both the carotid bodies (Meza et al, 2012;Shirahata et al, 1998) and chemoreceptive brainstem respiratory nuclei (Duncan et al, 2008;Shao et al, 2008;Shao and Feldman, 2002) alike. This has been shown in both the cat and mouse carotid body (Cohen et al, 2002;Shirahata et al, 1998) and in the brainstem of rats and human infants (Duncan et al, 2008;Shao et al, 2008;Shao and Feldman, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, ␣4-containing nAChRs reside in both the carotid bodies (Meza et al, 2012;Shirahata et al, 1998) and chemoreceptive brainstem respiratory nuclei (Duncan et al, 2008;Shao et al, 2008;Shao and Feldman, 2002) alike. This has been shown in both the cat and mouse carotid body (Cohen et al, 2002;Shirahata et al, 1998) and in the brainstem of rats and human infants (Duncan et al, 2008;Shao et al, 2008;Shao and Feldman, 2002). Further, the ␣4 receptor modulates excitatory control in the carotid body through the release of adenosine (Conde and Monteiro, 2006) and in the brainstem, inhibitory control through dopaminergic and GABAergic release (Klink et al, 2001;Marubio et al, 2003;Ross et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation